Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Capitanio, U; Ahyai, S; Graefen, M; Jeldres, C; Shariat, SF; Erbersdobler, A; Schlomm, T; Haese, A; Steuber, T; Heinzer, H; Perrotte, P; Péloquin, F; Pharand, D; Arjane, P; Huland, H; Karakiewicz, PI.
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology. 2008; 72(6):1208-11; discussion 1212-3
Doi: 10.1016/j.urology.2008.04.053
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Ahyai Sascha
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVES: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). METHODS: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult - administration & dosage
-
Aged - administration & dosage
-
Biopsy - administration & dosage
-
Cohort Studies - administration & dosage
-
Disease-Free Survival - administration & dosage
-
Humans - administration & dosage
-
Image Processing, Computer-Assisted - administration & dosage
-
Male - administration & dosage
-
Medical Oncology - methods
-
Middle Aged - administration & dosage
-
Prostate - pathology, surgery
-
Prostatectomy - methods
-
Prostatic Neoplasms - diagnosis, pathology
-
Recurrence - administration & dosage
-
Treatment Outcome - administration & dosage